Related Experiment Videos
Gastric dysplasia. A follow-up study
C Di Gregorio1, P Morandi, R Fante
1Istituto di Anatomia ed Istologia Patologica, Universita di Modena, Italy.
The American Journal of Gastroenterology
|October 1, 1993
Summary
Gastric dysplasia, a precancerous lesion, shows varying risks. Mild and moderate dysplasia often regress or stabilize, but severe dysplasia carries a high risk of progressing to gastric cancer, necessitating close monitoring.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Gastric dysplasia is recognized as a precancerous lesion of the stomach.
- Understanding the neoplastic risk associated with different grades of dysplasia is crucial for patient management.
Purpose of the Study:
- To evaluate the natural history and neoplastic progression of gastric dysplasia.
- To define the magnitude of cancer risk associated with mild, moderate, and severe gastric dysplasia.
Main Methods:
- A cohort of 99 patients with initial diagnoses of gastric dysplasia were followed.
- Endoscopic biopsies were used for initial diagnosis and subsequent monitoring.
- Histologic examination assessed the degree of dysplasia and its progression over time.
Main Results:
- Mild dysplasia regressed or was undetectable in 74% of patients, with 7% progressing to carcinoma.
- Moderate dysplasia regressed in 31% and was undetectable in 56%, but 13% progressed to cancer.
- Severe dysplasia showed a 60% progression to cancer, often detected within 3 months, indicating a high risk.
Conclusions:
- Gastric dysplasia, particularly severe dysplasia, poses a significant risk of progressing to gastric cancer.
- Annual endoscopic and histologic surveillance is recommended for patients with gastric dysplasia.
- Persistent severe dysplasia warrants consideration for gastrectomy due to high cancer risk.